Stegeman J A, Tielen M J, Kimman T G, Van Oirschot J T, Hunneman W A, Berndsen F W
Animal Health Service in the Southern Netherlands, Boxtel.
Vaccine. 1994 May;12(6):527-31. doi: 10.1016/0264-410x(94)90312-3.
The development of marker vaccines against pseudorabies virus (PRV) and companion diagnostic tests have enabled us to perform a unique field trial. In this study, the effect of intensive regional vaccination on pig-finishing herd immunity was directly measured by comparing the seroprevalence of antibodies to glycoprotein I in trial and control groups. The seroprevalence of infected finishing herds in the trial region decreased from 81% at the start of the trial to 19% after 2 years (p < 0.001). The mean seroprevalence of infected pigs in these herds diminished from 49 to 5% (p < 0.001). In the control group, representing routine PRV control, no significant change in seroprevalences was noticed.
抗伪狂犬病病毒(PRV)标记疫苗及配套诊断检测方法的研发,使我们能够开展一项独特的现场试验。在本研究中,通过比较试验组和对照组中针对糖蛋白I抗体的血清阳性率,直接测定了密集区域疫苗接种对育肥猪群免疫力的影响。试验区域内感染育肥猪群的血清阳性率从试验开始时的81%降至2年后的19%(p < 0.001)。这些猪群中感染猪的平均血清阳性率从49%降至5%(p < 0.001)。在代表常规PRV防控的对照组中,未观察到血清阳性率有显著变化。